Clal Biotechnology (Israel) Financial Indicators Patterns

CBI -- Israel Stock  

ILS 355.10  15.80  4.26%

We suggest you to use Clal Biotechnology fundamental analysis to see if markets are presently mispricing the company. In plain English you can use it to find out if Clal Biotechnology is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found thirty-one available fundamental indicators for Clal Biotechnology Industries Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Clal Biotechnology fundamentals including its Operating Margin, Revenue, Total Debt, as well as the relationship between Price to Earning and Net Income . Use Clal Biotechnology to protect against small markets fluctuations. The stock experiences very speculative upward sentiment.. Check odds of Clal Biotechnology to be traded at S337.35 in 30 days

Clal Biotechnology Company Summary

Clal Biotechnology competes with Kamada Ltd, Compugen Ltd, and Evogene Ltd. Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. Clal Biotechnology operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange.

Clal Biotechnology Current Asset vs Return On Equity

Clal Biotechnology Industries Ltd is number one stock in current asset category among related companies. It is rated second in return on equity category among related companies .

Clal Biotechnology Market Fundamentals

 Quote355.10
 Change(%) 4.26%
 Change15.80 
 Open370.9
 Low355.1
 High355.1
 Volume1.000
 ExchangeTLV

Distress Rating

Clal Biotechnology Financial Distress Probability

13% 
Chance of Financial Distress
Clal Biotechnology Industries Ltd has less than 13 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Clal Biotechnology

Compare Clal Biotechnology To Peers

Clal Biotechnology Opportunity Range

October 17, 2018 Opportunity Range

Check also Trending Equities. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.
Search macroaxis.com